► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Bidvest has countered a CFR Pharmaceuticals bid for South Africa's Adcock Ingram. Lex's Joseph Cotterill and Vincent Boland discuss what's behind this bid battle and who may prevail.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
Bidvest has countered a CFR Pharmaceuticals bid for South Africa's Adcock Ingram. Lex's Joseph Cotterill and Vincent Boland discuss what's behind this bid battle and who may prevail.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
Category
🗞
News